— Learn

Velox Peptides Guides

Educational resources for researchers working with HPLC-verified peptides — plain-English explainers, side-by-side compound comparisons, a research-terms glossary, and frequently asked questions. Everything you need to understand the science and the documentation behind each compound.

For scientific reference only — not medical advice. All content is derived from peer-reviewed preclinical and clinical research. Summaries are provided for scientific reference, not medical advice, diagnosis, or treatment. All compounds are for in vitro research use only. Not for human or veterinary consumption.

Research Summary
Retatrutide: Preclinical Research Overview
A GLP-1/GIP/glucagon triple agonist studied in preclinical and early clinical metabolic research.
Research Summary
BPC-157: Preclinical Research Overview
A synthetic pentadecapeptide studied in angiogenesis, tendon and ligament, and gastrointestinal repair models.
Research Summary
TB-500: Preclinical Research Overview
A thymosin β4 fragment studied for actin binding, cell migration, and angiogenesis in tissue-repair models.
Research Summary
Semax: Preclinical Research Overview
A neuropeptide studied for BDNF and NGF pathway activity in preclinical neuroscience models.
Research Summary
Selank: Preclinical Research Overview
A neuropeptide studied for anxiolytic effects and GABA pathway modulation in rodent models.
Research Summary
CJC-1295: Preclinical Research Overview
A modified GHRH analogue studied for growth-hormone pulse amplitude in preclinical models.
Research Summary
Tesamorelin: Preclinical Research Overview
A GHRH analogue studied for receptor activation and pulsatile GH secretion in rodent models.
Research Summary
GHK-Cu: Preclinical Research Overview
A naturally-occurring copper-tripeptide studied in dermal fibroblast and tissue-remodelling models.
Research Summary
MOTS-C: Preclinical Research Overview
A mitochondrially-encoded peptide studied for AMPK activation and metabolic signalling in rodent models.
Research Summary
NAD+: Preclinical Research Overview
A cellular cofactor studied for energy metabolism and sirtuin pathway activation in animal models.
Research Summary
KPV: Preclinical Research Overview
An alpha-MSH C-terminal tripeptide studied for NF-κB inhibition and mucosal inflammation models.
Research Summary
Melanotan II: Preclinical Research Overview
A melanocortin receptor agonist studied for pigmentation pathway signalling in rodent models.
Research Summary
Glutathione: Preclinical Research Overview
An endogenous tripeptide antioxidant studied for oxidative stress pathways in cellular and animal models.
Research Summary
DSIP: Preclinical Research Overview
A delta sleep-inducing neuropeptide studied for sleep modulation and stress response in rodent models.

Browse the compound catalogue

Every compound page includes a research overview, specification table, and batch testing summary.

View compounds →
Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.